TLX599-CDx

N/A

Report date: 2025/11/19 17:58:18
NME

Base Information

Drug NameTLX599-CDx
Drug Alias Name99mTc-iPSMA99Tc-PSMA99mTc-EDDAHYNIC-iPSMATc99m-iPSMA +[7] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsDiagnostic agentsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGrand Pharmaceutical （China） Co LtdTelix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTelix Pharmaceuticals LtdGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsDiagnostic agentsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A